21 - 23 April 2026
RAI Amsterdam
Are firms considering adopting the new UK/EU Research payment optionality? This session explores how the buy side is weighing client benefits, timing and approach, from CSA expansion / adoption and legal structuring to OMS readiness. We’ll discuss how trading, compliance, portfolio managers and brokers are approaching internally, and any commercial considerations influencing whether firms introduce in 2026, 2017 or not at all.
Check out the incredible speaker line-up to see who will be joining Brian.
Download The Latest Agenda